Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature's Bounty

140Citations
Citations of this article
291Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Medicinal plants have been used from the beginning of human civilization, which is mostly evident from the ancient script and traditional herbal medicine recipe. Despite the historically enriched demonstration about the use of plant as therapeutics, the pharmaceutical industries lack interest on phytochemical research compared with synthetic drug. Mostly, the absence of information about plant-based medicinal therapeutics is responsible to draw the attention of researchers to think about natural products as potential drug for detrimental diseases, such as cancer. This review will cover about clinically successful plant-based anticancer drugs and underappreciated, but potential, drugs to bridge the information gap between plant biologists and clinical researchers. Additionally, unprecedented advancement of synthetic chemistry, omics study to pin point the target genes/proteins, and efficient drug delivery system have made it easier for researchers to develop a phytochemical as an efficient anticancer drug.

Cite

CITATION STYLE

APA

Ashraf, M. A. (2020). Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty. BioMed Research International. Hindawi Limited. https://doi.org/10.1155/2020/8602879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free